Genprex, Inc. (GNPX)

Genprex, Inc. (GNPX) Company Bio


Genprex, Inc., a clinical stage gene therapy company, develops drugs to treat cancer. Its lead product candidate is Oncoprex, an active anti-cancer agent that is in Phase II clinical trials for the treatment of non-small cell lung cancer (NSCLC). It also conducts preclinical research for developing Oncoprex to be administered with immunotherapies in NSCLC; and research into other tumor suppressor genes associated with chromosome. The company was founded in 2009 and is based in Austin, Texas.

GNPX Daily Price Range
GNPX 52-Week Price Range
Add GNPX to Watchlist
Sign Up

GNPX - Live POWR Rating™

Overall POWR Rating

To view GNPX's real-time POWR Rating, sign up now.

Access Ratings for Free

GNPX News Stream

Event/Time News Detail Start End Change
Loading, please wait...
View All GNPX News

GNPX Stock Chart More Charts


GNPX Price/Volume Stats

Current price $1.79
Prev. close $1.80
Day low $1.79
Day high $1.86
50-day MA $1.58
200-day MA $2.95
52-week high $19.45
52-week low $0.95
Volume 13,800
Avg. volume 46,805
Dividend yield N/A
Market Cap 26.98M

GNPX Social Stream


Loading social stream, please wait...

View Full GNPX Social Stream

GNPX Returns

1-mo 20.54%
3-mo 64.22%
6-mo -20.44%
1-year N/A
3-year N/A
5-year N/A
YTD 62.73%
2018 N/A
2017 N/A
2016 N/A
2015 N/A
2014 N/A
Page generated in 0.2308 seconds.